1,293
Views
19
CrossRef citations to date
0
Altmetric
Review Article

Hepatic sarcoidosis: pathogenesis, clinical context, and treatment options

, , , &
Pages 1025-1030 | Received 06 Mar 2016, Accepted 05 Apr 2016, Published online: 13 May 2016

References

  • Judson MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med. 2007;28:83–101.
  • Gavilán F, Pereda T, Sousa JM, et al. Hepatic cirrhosis with sarcoid granulomas. Differential diagnosis and liver transplantation: a case report. Transplant Proc. 2003;35:713–714.
  • Cozier YC, Berman JS, Palmer JR. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest. 2011;139:144–150.
  • Saidha S, Sotirchos ES, Eckstein C. Etiology of sarcoidosis: does infection play a role? Yale J Biol Med. 2012;85:133–141.
  • Smith G, Brownell I, Sanchez M, et al. Advances in the genetics of sarcoidosis. Clin Genet. 2008;73:401–412.
  • Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol. 2006;5:251–256.
  • Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon. 2009;55:675–692.
  • Irani SK, Dobbins WO. Hepatic granulomas: review of 73 patients from one hospital and survey of the literature. J Clin Gastroenterol. 1979;1:131–143.
  • Devaney K, Goodman ZD, Epstein MS, et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol. 1993;17:1272–1280.
  • Vatti R, Sharma OP. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14:73–76.
  • Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;22:2153–2165.
  • Zissel G, Prasse A, Muller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med. 2010;31:390–403.
  • Schürmann M. Genetics of sarcoidosis. Semin Respir Crit Care Med. 2003;24:213–222.
  • Lazarus A. Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Mon. 2009;55:649–660.
  • Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014;383:1155–1167.
  • Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–1330.
  • Modaresi Esfeh J, Culver D, Plesec T, et al. Clinical presentation and protocol for management of hepatic sarcoidosis. Expert Rev Gastroenterol Hepatol. 2015;9:349–358.
  • Dulai PS, Rothstein RI. Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis. J Clin Gastroenterol. 2012;46:367–374.
  • Maddrey WC, Johns CJ, Boitnott JK, et al. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore). 1970;49:375–395.
  • Cremers J, Drent M, Driessen A, et al. Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol. 2012;24:17–24.
  • Lebacq EG, Heller F. LP-X test in sarcoidosis patients with liver involvement: comparison with other liver function tests. Ann N Y Acad Sci. 1976;278:439–444.
  • Tadros M, Forouhar F, Wu GY. Hepatic sarcoidosis. J Clin Transl Hepatol. 2013;1:87–93.
  • Inuzuka S, Ueno T, Tateishi H, et al. A patient with hepatic granuloma formation and angiotensin-converting enzyme production by granuloma cells during clinical relapse of hepatitis A. Pathol Int. 1994;44:391–397.
  • Fløe A, Hoffmann HJ, Nissen PH, et al. Genotyping increases the yield of angiotensin-converting enzyme in sarcoidosis-a systematic review. Dan Med J. 2014;61:A4815.
  • Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975;59:365–372.
  • Studdy PR, Bird R. Serum angiotensin converting enzyme in sarcoidosis – its value in present clinical practice. Ann Clin Biochem. 1989;26:13–18.
  • Inoue M, Chiba T, Zen Y, et al. Hepatic sarcoidosis with an increased serum level of immunoglobulin G4. Intern Med. 2012;51:3095–3098.
  • Rudzki C, Ishak KG, Zimmerman HJ. Chronic intrahepatic cholestasis of sarcoidosis. Am J Med. 1975;59:373–387.
  • Thomas E, Micci D. Chronic intrahepatic cholestasis with granulomas and biliary cirrhosis. Enigmatic disease and therapeutic dilemma. JAMA. 1977;238:337–338.
  • Bass NM, Burroughs AK, Scheuer PJ, et al. Chronic intrahepatic cholestasis due to sarcoidosis. Gut. 1982;23:417–421.
  • Pereira-Lima J, Schaffner F. Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis. Report of two cases. Am J Med. 1987;83:144–148.
  • Farouj NE, Cadranel JF, Mofredj A, et al. Ductopenia related liver sarcoidosis. World J Hepatol. 2011;3:170–174.
  • Blich M, Edoute Y. Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol. 2004;19:732–737.
  • Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis. Chronic non suppurative destructive cholangitis. Am J Pathol. 1965;46:387–407.
  • Ebert E. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol. 2008;103:3184–3192.
  • Alam I, Levenson SD, Ferrell LD, et al. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig Dis Sci. 1997;42:1295–1301.
  • Romero-Gómez M, Suárez-García E, Otero MA, et al. Sarcoidosis sclerosing cholangitis and chronic atrophic autoimmune gastritis: a case of infiltrative sclerosing cholangitis. J Clin Gastroenterol. 1998;27:162–165.
  • Ishak KG. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc. 1998;73:467–472.
  • Bloom R, Sybert A, Mascatello VJ. Granulomatous biliary tract obstruction due to sarcoidosis. Report of a case and review of the literature. Am Rev Respir Dis. 1978;117:783–787.
  • Rezeig MA, Fashir BM. Biliary tract obstruction due to sarcoidosis: a case report. Am J Gastroenterol. 1996;92:527–528.
  • Baughman RP. Sarcoidosis usual and unusual manifestations. Chest. 1988;94:165–170.
  • Valla D, Pessegueiro-Miranda H, Degott C, et al. Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med. 1987;63:531–544.
  • Moreno-Merlo F, Wanless IR, Shimamatsu K, et al. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology. 1997;26:554–560.
  • Natalino MR, Goyette RE, Owensby LC, et al. The Budd Chiari syndrome in sarcoidosis. JAMA. 1978;239:2657–2658.
  • Russi EW, Bansky G, Pfaltz M, et al. Budd Chiari syndrome in sarcoidosis. Am J Gastroenterol. 1986;81:71–75.
  • Aravinthan A, Gelson W, Limbu A, et al. Hepatic sarcoidosis complicating treatment-naive viral hepatitis. World J Hepatol. 2012;4:402–405.
  • Moudden MK, Ziadi T, Al Bouzidi A. Sarcoidose in patient with chronic hepatitis C treated with pegylated interferon. Rev Pneumol Clin. 2014;70:362–365.
  • Fiel MI, Shukla D, Saraf N, et al. Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation. Transpl Infect Dis. 2008;10:184–189.
  • Brjalin V, Salupere R, Tefanova V, et al. Sarcoidosis and chronic hepatitis C: a case report. World J Gastroenterol. 2012;18:5816–5820.
  • Ozaras R, Tahan V, Mert A, et al. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol. 2004;38:449–452.
  • Snyder N, Martinez JG, Xiao SY. Chronic hepatitis C is a common associated with hepatic granulomas. World J Gastroenterol. 2008;14:6366–6369.
  • Fallahi P, Ferri C, Ferrari SM, et al. Cytokines and HCV-related disorders. Clin Dev Immunol. 2012;468107.
  • Karaosmanoğlu AD, Onur MR, Saini S, et al. Imaging of hepatobiliary involvement in sarcoidosis. Abdom Imaging. 2015;40:3330–3337.
  • Fetzer DT, Rees MA, Dasyam AK, et al. Hepatic sarcoidosis in patients presenting with liver dysfunction: imaging appearance, pathological correlation and disease evolution. Eur Radiol. 2016;16:1–9.
  • Kessler A, Mitchell DG, Israel HL, et al. Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imaging. 1993;18:159–163.
  • Gezer NS, Başara I, Altay C, et al. Abdominal sarcoidosis: cross-sectional imaging findings. Diagn Interv Radiol. 2015;21:111–117.
  • Suzuki K, Morise Z, Furuta S, et al. Hepatic sarcoidosis mimicking hilar cholangiocarcinoma: case report and review of the literature. Case Rep Gastroenterol. 2011;5:152–158.
  • Cremers JP, Drent M, Baughman RP, et al. Therapeutic approach of hepatic sarcoidosis. Curr Opin Pulm Med. 2012;18:472–482.
  • Kennedy PT, Zakaria N, Modawi SB, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol. 2006;18:721–726.
  • Moller DR. Treatment of sarcoidosis – from a basic science point of view. J Intern Med. 2003;253:31–40.
  • Mueller S, Boehme MW, Hofmann WJ, et al. Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand J Gastroenterol. 2000;35:1003–1008.
  • B´echeur H, Dall’osto H, Chatellier G, et al. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis. Dig Dis Sci. 1997;42:789–791.
  • Alenezi B, Lamoureux E, Alpert L, et al. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig Dis Sci. 2005;50:196–200.
  • Baratta L, Cascino A, Delfino M, et al. Ursodeoxycholic acid treatment in abdominal sarcoidosis. Dig Dis Sci. 2000;45:1559–1562.
  • Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci. 1990;299:153–157.
  • Baughman RP, Koehler A, Bejarano PA, et al., Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med. 2003;163:615–620.
  • Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol. 2008;23:1942.
  • Ulbricht KU, Stoll M, Bierwirth J, et al. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum. 2003;48:3542–3543.
  • Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005;127:1064–1071.
  • Saleh S, Ghodsian S, Yakimova V, et al. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med. 2006;100:2053–2059.
  • Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31:1189–1196.
  • Denys BG, Bogaerts Y, Coenegrachts KL, et al. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin Sci (Lond). 2007;112:281–289.
  • Boots AW, Drent M, de Boer VC, et al. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr. 2011;30:506–512.
  • Hughes GS Jr, Kataria YP, O’Brien TF Jr, Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil. South Med J. 1983;76:1440–1442.
  • Casavilla FA, Gordon R, Wright HI, et al. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med. 1993;118:865–866.
  • Das D, Smith A, Warnes TW. Hepatic sarcoidosis and renal carcinoma. J Clin Gastroenterol. 1999;28:61–63.
  • Nguyen YT, Dupuy A, Cordoliani F, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol. 2004;50:235–241.
  • Lazar CA, Culver DA. Treatment of sarcoidosis. Semin Respir Crit Care Med. 2010;31:501–518.
  • Park MK, Fontana Jr, Babaali H, et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26:121–131.
  • Vanatta JM, Modanlou KA, Dean AG, et al. Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: an analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl. 2011;17:1027–1034.
  • Lipson EJ, Fiel MI, Florman SS, et al. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant. 2005;19:487–491.
  • Cengiz C, Rodriguez-Davalos M, deBoccardo G, et al. Recurrent hepatic sarcoidosis postliver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl. 2005;11:1611–1614.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.